The intestinal microbiota and cellular therapy: implications for impact and mechanisms

2.

Henig

I

,

Zuckerman

T

.

Hematopoietic stem cell transplantation—50 years of evolution and future perspectives

.

Rambam Maimonides Med J

.

2014

;

5

(

4

):

e0028

.

3.

Rosenberg

SA

,

Packard

BS

,

Aebersold

PM

, et al.

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma

.

N Engl J Med

.

1988

;

319

(

25

):

1676

-

1680

.

4.

Rosenberg

SA

,

Yannelli

JR

,

Yang

JC

, et al.

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2

.

J Natl Cancer Inst

.

1994

;

86

(

15

):

1159

-

1166

.

5.

Lin

X

,

Lee

S

,

Sharma

P

,

George

B

,

Scott

J

.

Summary of US Food and Drug Administration chimeric antigen receptor (CAR) T-cell biologics license application approvals from a statistical perspective

.

J Clin Orthod

.

2022

;

40

(

30

):

3501

-

3509

.

6.

Mullard

A

.

FDA approval of Immunocore’s first-in-class TCR therapeutic broadens depth of the T cell engager platform

.

Nat Rev Drug Discov

.

2022

;

21

(

3

):

170

.

7.

Zeiser

R

,

Blazar

BR

.

Acute graft-versus-host disease–biologic process, prevention, and therapy

.

N Engl J Med

.

2017

;

377

(

22

):

2167

-

2179

.

8.

Zeiser

R

,

Blazar

BR

.

Pathophysiology of chronic graft-versus-host disease and therapeutic targets

.

N Engl J Med

.

2017

;

377

(

26

):

2565

-

2579

.

9.

Dougan

M

,

Luoma

AM

,

Dougan

SK

,

Wucherpfennig

KW

.

Understanding and treating the inflammatory adverse events of cancer immunotherapy

.

Cell

.

2021

;

184

(

6

):

1575

-

1588

.

10.

Fan

Y

,

Pedersen

O

.

Gut microbiota in human metabolic health and disease

.

Nat Rev Microbiol

.

2021

;

19

(

1

):

55

-

71

.

11.

Sender

R

,

Fuchs

S

,

Milo

R

.

Revised estimates for the number of human and bacteria cells in the body

.

PLoS Biol

.

2016

;

14

(

8

):

e1002533

.

12.

Schroeder

BO

,

Bäckhed

F

.

Signals from the gut microbiota to distant organs in physiology and disease

.

Nat Med

.

2016

;

22

(

10

):

1079

-

1089

.

13.

Dickinson

AM

,

Norden

J

,

Li

S

, et al.

Graft-versus-leukemia effect following hematopoietic stem cell transplantation for leukemia

.

Front Immunol

.

2017

;

8

:

496

-

511

.

14.

Taur

Y

,

Xavier

JB

,

Lipuma

L

, et al.

Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation

.

Clin Infect Dis

.

2012

;

55

(

7

):

905

-

914

.

15.

Morjaria

S

,

Schluter

J

,

Taylor

BP

, et al.

Antibiotic-induced shifts in fecal microbiota density and composition during hematopoietic stem cell transplantation

.

Infect Immun

.

2019

;

87

(

9

):

e00206-19

.

16.

Khan

N

,

Lindner

S

,

Gomes

ALC

, et al.

Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study

.

Blood

.

2021

;

137

(

11

):

1527

-

1537

.

17.

Miltiadous

O

,

Waters

NR

,

Andrlová

H

, et al.

Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant

.

Blood

.

2022

;

139

(

18

):

2758

-

2769

.

18.

Masetti

R

,

Leardini

D

,

Muratore

E

, et al.

Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children

.

Blood

.

2023

;

142

(

16

):

1387

-

1398

.

19.

Peled

JU

,

Gomes

ALC

,

Devlin

SM

, et al.

Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation

.

N Engl J Med

.

2020

;

382

(

9

):

822

-

834

.

20.

Taur

Y

,

Jenq

RR

,

Perales

M-A

, et al.

The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation

.

Blood

.

2014

;

124

(

7

):

1174

-

1182

.

21.

D’Angelo

C

,

Sudakaran

S

,

Asimakopoulos

F

, et al.

Perturbation of the gut microbiome and association with outcomes following autologous stem cell transplantation in patients with multiple myeloma

.

Leuk Lymphoma

.

2023

;

64

(

1

):

87

-

97

.

22.

Montassier

E

,

Al-Ghalith

GA

,

Ward

T

, et al.

Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection

.

Genome Med

.

2016

;

8

(

1

):

49

-

59

.

23.

Yin

G

,

Guo

Y

,

Ding

Q

, et al.

Klebsiella quasipneumoniae in intestine damages bile acid metabolism in hematopoietic stem cell transplantation patients with bloodstream infection

.

J Transl Med

.

2023

;

21

(

1

):

230

-

244

.

24.

Golob

JL

,

Pergam

SA

,

Srinivasan

S

, et al.

Stool microbiota at neutrophil recovery is predictive for severe acute graft vs host disease after hematopoietic cell transplantation

.

Clin Infect Dis

.

2017

;

65

(

12

):

1984

-

1991

.

25.

El Jurdi

N

,

Holtan

SG

,

Hoeschen

A

, et al.

Pre-transplant and longitudinal changes in faecal microbiome characteristics are associated with subsequent development of chronic graft-versus-host disease

.

Br J Haematol

.

2023

;

203

(

2

):

288

-

294

.

26.

El Jurdi

N

,

Filali-Mouhim

A

,

Salem

I

, et al.

Gastrointestinal microbiome and mycobiome changes during autologous transplantation for multiple myeloma: results of a prospective pilot study

.

Biol Blood Marrow Transplant

.

2019

;

25

(

8

):

1511

-

1519

.

27.

Harris

B

,

Morjaria

SM

,

Littmann

ER

, et al.

Gut microbiota predict pulmonary infiltrates after allogeneic hematopoietic cell transplantation

.

Am J Respir Crit Care Med

.

2016

;

194

(

4

):

450

-

463

.

28.

Scordo

M

,

Shah

GL

,

Adintori

PA

, et al.

A prospective study of dysgeusia and related symptoms in patients with multiple myeloma after autologous hematopoietic cell transplantation

.

Cancer

.

2022

;

128

(

21

):

3850

-

3859

.

29.

Andrlová

H

,

Miltiadous

O

,

Kousa

AI

, et al.

MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT

.

Sci Transl Med

.

2022

;

14

(

646

):

eabj2829

.

30.

Hu

Y

,

Li

J

,

Ni

F

, et al.

CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies

.

Nat Commun

.

2022

;

13

(

1

):

5313

-

5326

.

31.

Staffas

A

,

Burgos da Silva

M

,

Slingerland

AE

, et al.

Nutritional support from the intestinal microbiota improves hematopoietic reconstitution after bone marrow transplantation in mice

.

Cell Host Microbe

.

2018

;

23

(

4

):

447

-

457.e4

.

32.

Seike

K

,

Kiledal

A

,

Fujiwara

H

, et al.

Ambient oxygen levels regulate intestinal dysbiosis and GVHD severity after allogeneic stem cell transplantation

.

Immunity

.

2023

;

56

(

2

):

353

-

368.e6

.

33.

Sofi

MH

,

Wu

Y

,

Ticer

T

, et al.

A single strain of Bacteroides fragilis protects gut integrity and reduces GVHD

.

JCI Insight

.

2021

;

6

(

3

):

e136841

.

34.

Pan

P

,

Atkinson

SN

,

Taylor

B

, et al.

Retinoic acid signaling modulates recipient gut barrier integrity and microbiota after allogeneic hematopoietic stem cell transplantation in mice

.

Front Immunol

.

2021

;

12

:

749002

.

35.

Bowerman

KL

,

Varelias

A

,

Lachner

N

,

Kuns

RD

,

Hill

GR

,

Hugenholtz

P

.

Continuous pre- and post-transplant exposure to a disease-associated gut microbiome promotes hyper-acute graft-versus-host disease in wild-type mice

.

Gut Microb

.

2020

;

11

(

4

):

754

-

770

.

36.

Uribe-Herranz

M

,

Beghi

S

,

Ruella

M

, et al.

Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy

.

Mol Ther

.

2023

;

31

(

3

):

686

-

700

.

37.

Peled

JU

,

Devlin

SM

,

Staffas

A

, et al.

Intestinal microbiota and relapse after hematopoietic-cell transplantation

.

J Clin Orthod

.

2017

;

35

(

15

):

1650

-

1659

.

38.

Burgos da Silva

M

,

Ponce

DM

,

Dai

A

, et al.

Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease

.

Blood

.

2022

;

140

(

22

):

2385

-

2397

.

39.

Markey

KA

,

Schluter

J

,

Gomes

ALC

, et al.

The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD

.

Blood

.

2020

;

136

(

1

):

130

-

136

.

40.

Stein-Thoeringer

CK

,

Nichols

KB

,

Lazrak

A

, et al.

Lactose drives enterococcus expansion to promote graft-versus-host disease

.

Science

.

2019

;

366

(

6469

):

1143

-

1149

.

41.

Schluter

J

,

Peled

JU

,

Taylor

BP

, et al.

The gut microbiota is associated with immune cell dynamics in humans

.

Nature

.

2020

;

588

(

7837

):

303

-

307

.

42.

Vallet

N

,

Salmona

M

,

Malet-Villemagne

J

, et al.

Circulating T cell profiles associate with enterotype signatures underlying hematological malignancy relapses

.

Cell Host Microbe

.

2023

;

31

(

8

):

1386

-

1403.e6

.

43.

Shono

Y

,

van den Brink

MRM

.

Gut microbiota injury in allogeneic haematopoietic stem cell transplantation

.

Nat Rev Cancer

.

2018

;

18

(

5

):

283

-

295

.

44.

Nguyen

CL

,

Docampo

MD

,

van den Brink

MR

,

Markey

KA

.

The role of the intestinal microbiota in allogeneic HCT: clinical associations and preclinical mechanisms

.

Curr Opin Genet Dev

.

2021

;

66

:

25

-

35

.

45.

Shouval

R

,

Waters

NR

,

Gomes

ALC

, et al.

Conditioning regimens are associated with distinct patterns of microbiota injury in allogeneic hematopoietic cell transplantation

.

Clin Cancer Res

.

2023

;

29

(

1

):

165

-

173

.

46.

Liao

C

,

Taylor

BP

,

Ceccarani

C

, et al.

Compilation of longitudinal microbiota data and hospitalome from hematopoietic cell transplantation patients

.

Sci Data

.

2021

;

8

(

1

):

71

-

82

.

47.

Routy

B

,

Letendre

C

,

Enot

D

, et al.

The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation

.

OncoImmunology

.

2017

;

6

(

1

):

e1258506

.

48.

Tanaka

JS

,

Young

RR

,

Heston

SM

, et al.

Anaerobic antibiotics and the risk of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

.

Biol Blood Marrow Transplant

.

2020

;

26

(

11

):

2053

-

2060

.

49.

Shono

Y

,

Docampo

MD

,

Peled

JU

, et al.

Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice

.

Sci Transl Med

.

2016

;

8

(

339

):

339ra71

.

50.

Weber

D

,

Jenq

RR

,

Peled

JU

, et al.

Microbiota disruption induced by early use of broad-spectrum antibiotics is an independent risk factor of outcome after allogeneic stem cell transplantation

.

Biol Blood Marrow Transplant

.

2017

;

23

(

5

):

845

-

852

.

51.

Vallet

N

,

Le Grand

S

,

Bondeelle

L

, et al.

Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation

.

Blood

.

2022

;

140

(

23

):

2500

-

2513

.

52.

Ogimi

C

,

Krantz

EM

,

Golob

JL

, et al.

Exposure to antibiotics with anaerobic activity before respiratory viral infection is associated with respiratory disease progression after hematopoietic cell transplant

.

Bone Marrow Transplant

.

2022

;

57

(

12

):

1765

-

1773

.

53.

Zhang

S

,

Shanley

R

,

Weisdorf

DJ

,

Rashidi

A

.

Vancomycin use and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation

.

Blood Adv

.

2020

;

4

(

12

):

2640

-

2643

.

54.

Haak

BW

,

Littmann

ER

,

Chaubard

J-L

, et al.

Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT

.

Blood

.

2018

;

131

(

26

):

2978

-

2986

.

55.

Satlin

MJ

,

Chen

L

,

Douglass

C

, et al.

Colonization with fluoroquinolone-resistant enterobacterales decreases the effectiveness of fluoroquinolone prophylaxis in hematopoietic cell transplant recipients

.

Clin Infect Dis

.

2021

;

73

(

7

):

1257

-

1265

.

56.

Vossen

JM

,

Guiot

HFL

,

Lankester

AC

, et al.

Complete suppression of the gut microbiome prevents acute graft-versus-host disease following allogeneic bone marrow transplantation

.

PLoS One

.

2014

;

9

(

9

):

e105706

.

57.

Rashidi

A

,

Gao

F

,

Fredricks

DN

, et al.

Analysis of antibiotic exposure and development of acute graft-vs-host disease following allogeneic hematopoietic cell transplantation

.

JAMA Netw Open

.

2023

;

6

(

6

):

e2317188

.

58.

Elgarten

CW

,

Li

Y

,

Getz

KD

, et al.

Broad-spectrum antibiotics and risk of graft-versus-host disease in pediatric patients undergoing transplantation for acute leukemia: association of carbapenem use with the risk of acute graft-versus-host disease

.

Transplant Cell Ther

.

2021

;

27

(

2

):

177.e1

-

177.e8

.

59.

Hayase

E

,

Hayase

T

,

Jamal

MA

, et al.

Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease

.

Cell

.

2022

;

185

(

20

):

3705

-

3719.e14

.

60.

Simms-Waldrip

TR

,

Sunkersett

G

,

Coughlin

LA

, et al.

Antibiotic-induced depletion of anti-inflammatory clostridia is associated with the development of graft-versus-host disease in pediatric stem cell transplantation patients

.

Biol Blood Marrow Transplant

.

2017

;

23

(

5

):

820

-

829

.

61.

Solano

C

,

Gutierrez

A

,

Martinez

F

, et al.

Prophylaxis of early bacterial infections after autologous peripheral blood stem cell transplantation (PBSCT): a matched-pair study comparing oral fluoroquinolones and intravenous piperacillin–tazobactam

.

Bone Marrow Transplant

.

2005

;

36

(

1

):

59

-

65

.

62.

Eleutherakis-Papaiakovou

E

,

Kostis

E

,

Migkou

M

, et al.

Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial

.

Am J Hematol

.

2010

;

85

(

11

):

863

-

867

.

63.

Beelen

DW

,

Elmaagacli

A

,

Müller

K-D

,

Hirche

H

,

Schaefer

UW

.

Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospective randomized trial

.

Blood

.

1999

;

93

(

10

):

3267

-

3275

.

64.

Severyn

CJ

,

Siranosian

BA

,

Kong

ST-J

, et al.

Microbiota dynamics in a randomized trial of gut decontamination during allogeneic hematopoietic cell transplantation

.

JCI Insight

.

2022

;

7

(

7

):

e154344

.

65.

Bansal

R

,

Park

H

,

Taborda

CC

, et al.

Antibiotic exposure, not alloreactivity, is the major driver of microbiome changes in hematopoietic cell transplantation

.

Transplant Cell Ther

.

2022

;

28

(

3

):

135

-

144

.

66.

Baydoun

M

,

Otrock

ZK

,

Okaily

S

, et al.

Prophylactic administration of doxycycline reduces central venous catheter infections in patients undergoing hematopoietic cell transplantation

.

Mediterr J Hematol Infect Dis

.

2013

;

5

(

1

):

e2013015

.

67.

Pérez-Simón

JA

,

García-Escobar

I

,

Martinez

J

, et al.

Antibiotic prophylaxis with meropenem after allogeneic stem cell transplantation

.

Bone Marrow Transplant

.

2004

;

33

(

2

):

183

-

187

.

68.

Smith

M

,

Dai

A

,

Ghilardi

G

, et al.

Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

.

Nat Med

.

2022

;

28

(

4

):

713

-

723

.

69.

Stein-Thoeringer

CK

,

Saini

NY

,

Zamir

E

, et al.

A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy

.

Nat Med

.

2023

;

29

(

4

):

906

-

916

.

70.

Zhai

B

,

Ola

M

,

Rolling

T

, et al.

High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis

.

Nat Med

.

2020

;

26

(

1

):

59

-

64

.

71.

Rolling

T

,

Zhai

B

,

Gjonbalaj

M

, et al.

Haematopoietic cell transplantation outcomes are linked to intestinal mycobiota dynamics and an expansion of Candida parapsilosis complex species

.

Nat Microbiol

.

2021

;

6

(

12

):

1505

-

1515

.

72.

Naghavian

R

,

Faigle

W

,

Oldrati

P

, et al.

Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma

.

Nature

.

2023

;

617

(

7962

):

807

-

817

.

73.

Daillère

R

,

Vétizou

M

,

Waldschmitt

N

, et al.

Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects

.

Immunity

.

2016

;

45

(

4

):

931

-

943

.

74.

Hamada

T

,

Zhang

X

,

Mima

K

, et al.

Fusobacterium nucleatum in colorectal cancer relates to immune response differentially by tumor microsatellite instability status

.

Cancer Immunol Res

.

2018

;

6

(

11

):

1327

-

1336

.

75.

Yu

Q

,

Newsome

RC

,

Beveridge

M

, et al.

Intestinal microbiota modulates pancreatic carcinogenesis through intratumoral natural killer cells

.

Gut Microb

.

2022

;

14

(

1

):

2112881

.

76.

Lam

KC

,

Araya

RE

,

Huang

A

, et al.

Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment

.

Cell

.

2021

;

184

(

21

):

5338

-

5356.e21

.

77.

Shafer

P

,

Kelly

LM

,

Hoyos

V

.

Cancer therapy with TCR-engineered T cells: current strategies, challenges, and prospects

.

Front Immunol

.

2022

;

13

:

835762

.

78.

Viaud

S

,

Saccheri

F

,

Mignot

G

, et al.

The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide

.

Science

.

2013

;

342

(

6161

):

971

-

976

.

79.

Kuczma

MP

,

Ding

Z-C

,

Li

T

, et al.

The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells

.

Oncotarget

.

2017

;

8

(

67

):

111931

-

111942

.

80.

Bauer

MA

,

Kainz

K

,

Carmona-Gutierrez

D

,

Madeo

F

.

Microbial wars: competition in ecological niches and within the microbiome

.

Microb Cell

.

2018

;

5

(

5

):

215

-

219

.

81.

Cerboni

S

,

Jeremiah

N

,

Gentili

M

, et al.

Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes

.

J Exp Med

.

2017

;

214

(

6

):

1769

-

1785

.

82.

Curran

E

,

Chen

X

,

Corrales

L

, et al.

STING pathway activation stimulates potent immunity against acute myeloid leukemia

.

Cell Rep

.

2016

;

15

(

11

):

2357

-

2366

.

83.

Nicolai

CJ

,

Wolf

N

,

Chang

I-C

, et al.

NK cells mediate clearance of CD8+ T cell–resistant tumors in response to STING agonists

.

Sci Immunol

.

2020

;

5

(

45

):

eaaz2738

.

84.

Luu

M

,

Riester

Z

,

Baldrich

A

, et al.

Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer

.

Nat Commun

.

2021

;

12

(

1

):

4077

-

4088

.

85.

Luu

M

,

Weigand

K

,

Wedi

F

, et al.

Regulation of the effector function of CD8+ T cells by gut microbiota-derived metabolite butyrate

.

Sci Rep

.

2018

;

8

(

1

):

14430

.

86.

Docampo

MD

,

da Silva

MB

,

Lazrak

A

, et al.

Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host disease

.

Blood

.

2022

;

139

(

15

):

2392

-

2405

.

87.

Tian

P

,

Yang

W

,

Guo

X

, et al.

Early life gut microbiota sustains liver-resident natural killer cells maturation via the butyrate-IL-18 axis

.

Nat Commun

.

2023

;

14

(

1

):

1710

-

1725

.

88.

Jia

D

,

Wang

Q

,

Qi

Y

, et al.

Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer

.

Cell

.

2024

;

187

(

7

):

1651

-

1665.e21

.

89.

Lindner

S

,

Miltiadous

O

,

Ramos

RJF

, et al.

Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host disease

.

Nat Microbiol

.

2024

;

9

(

3

):

614

-

630

.

90.

Haring

E

,

Uhl

FM

,

Andrieux

G

, et al.

Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect

.

Haematologica

.

2021

;

106

(

8

):

2131

-

2146

.

91.

Ma

S

,

Wu

Q

,

Wu

W

, et al.

Urolithin A Hijacks ERK1/2-ULK1 cascade to improve CD8+ T cell fitness for antitumor immunity

.

Adv Sci

.

2024

;

11

(

18

):

2310065

.

92.

Paulos

CM

,

Wrzesinski

C

,

Kaiser

Andrew

, et al.

Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8⁺ T cells via TLR4 signaling

.

J Clin Invest

.

2007

;

117

(

8

):

2197

-

2204

.

93.

Zhang

Q

,

Zhao

Q

,

Li

T

, et al.

Lactobacillus plantarum-derived indole-3-lactic acid ameliorates colorectal tumorigenesis via epigenetic regulation of CD8+ T cell immunity

.

Cell Metab

.

2023

;

35

(

6

):

943

-

960.e9

.

94.

Agliardi

G

,

Liuzzi

AR

,

Hotblack

A

, et al.

Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma

.

Nat Commun

.

2021

;

12

(

1

):

444

-

454

.

95.

Landoni

E

,

Woodcock

MG

,

Barragan

G

, et al.

IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity

.

Nat Commun

.

2024

;

15

(

1

):

89

-

104

.

96.

Wang

H

,

Jiang

D

,

Liu

L

, et al.

Spermidine promotes Nb CAR-T mediated cytotoxicity to lymphoma cells through elevating proliferation and memory

.

OTT

.

2022

;

15

:

1229

-

1243

.

97.

Denk

D

,

Petrocelli

V

,

Conche

C

, et al.

Expansion of T memory stem cells with superior anti-tumor immunity by Urolithin A-induced mitophagy

.

Immunity

.

2022

;

55

(

11

):

2059

-

2073.e8

.

98.

Klysz

DD

,

Fowler

C

,

Malipatlolla

M

, et al.

Inosine induces stemness features in CAR-T cells and enhances potency

.

Cancer Cell

.

2024

;

42

(

2

):

266

-

282.e8

.

99.

Rafei

H

,

Jenq

RR

.

Microbiome-intestine cross talk during acute graft-versus-host disease

.

Blood

.

2020

;

136

(

4

):

401

-

409

.

100.

Schwab

L

,

Goroncy

L

,

Palaniyandi

S

, et al.

Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage

.

Nat Med

.

2014

;

20

(

6

):

648

-

654

.

101.

Hossain

MS

,

Jaye

DL

,

Pollack

BP

, et al.

Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity

.

J Immunol

.

2011

;

187

(

10

):

5130

-

5140

.

102.

Bader

CS

,

Jin

L

,

Levy

RB

.

STING and transplantation: can targeting this pathway improve outcomes?

.

Blood

.

2021

;

137

(

14

):

1871

-

1878

.

103.

Fischer

JC

,

Bscheider

M

,

Eisenkolb

G

, et al.

RIG-I/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injury

.

Sci Transl Med

.

2017

;

9

(

386

):

eaag2513

.

104.

Fischer

JC

,

Bscheider

M

,

Göttert

S

, et al.

Type I interferon signaling before hematopoietic stem cell transplantation lowers donor T cell activation via reduced allogenicity of recipient cells

.

Sci Rep

.

2019

;

9

(

1

):

14955

.

105.

Michonneau

D

,

Latis

E

,

Curis

E

, et al.

Metabolomics analysis of human acute graft-versus-host disease reveals changes in host and microbiota-derived metabolites

.

Nat Commun

.

2019

;

10

(

1

):

5695

-

5709

.

106.

Romick-Rosendale

LE

,

Haslam

DB

,

Lane

A

, et al.

Antibiotic exposure and reduced short chain fatty acid production after hematopoietic stem cell transplant

.

Biol Blood Marrow Transplant

.

2018

;

24

(

12

):

2418

-

2424

.

107.

Mathewson

ND

,

Jenq

R

,

Mathew

AV

, et al.

Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease

.

Nat Immunol

.

2016

;

17

(

5

):

505

-

513

.

108.

Zheng

Y

,

Josefowicz

S

,

Chaudhry

A

,

Peng

XP

,

Forbush

K

,

Rudensky

AY

.

Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate

.

Nature

.

2010

;

463

(

7282

):

808

-

812

.

109.

Fujiwara

H

,

Docampo

MD

,

Riwes

M

, et al.

Microbial metabolite sensor GPR43 controls severity of experimental GVHD

.

Nat Commun

.

2018

;

9

(

1

):

3674

-

3688

.

110.

Smith

PM

,

Howitt

MR

,

Panikov

N

, et al.

The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis

.

Science

.

2013

;

341

(

6145

):

569

-

573

.

111.

Swimm

A

,

Giver

CR

,

DeFilipp

Z

, et al.

Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease

.

Blood

.

2018

;

132

(

23

):

2506

-

2519

.

112.

Henry

CJ

,

Ornelles

DA

,

Mitchell

LM

,

Brzoza-Lewis

KL

,

Hiltbold

EM

.

IL-12 produced by dendritic cells augments CD8+ T cell activation through the production of the chemokines CCL1 and CCL17

.

J Immunol

.

2008

;

181

(

12

):

8576

-

8584

.

113.

Cong

J

,

Liu

P

,

Han

Z

, et al.

Bile acids modified by the intestinal microbiota promote colorectal cancer growth by suppressing CD8+ T cell effector functions

.

Immunity

.

2024

;

57

(

4

):

876

-

889.e11

.

114.

Hang

S

,

Paik

D

,

Yao

L

, et al.

Bile acid metabolites control TH17 and Treg cell differentiation

.

Nature

.

2019

;

576

(

7785

):

143

-

148

.

115.

Campbell

C

,

McKenney

PT

,

Konstantinovsky

D

, et al.

Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells

.

Nature

.

2020

;

581

(

7809

):

475

-

479

.

116.

Tofalo

R

,

Cocchi

S

,

Suzzi

G

.

Polyamines and gut microbiota

.

Front Nutr

.

2019

;

6

:

16

.

117.

Shouval

R

,

Eshel

A

,

Dubovski

B

, et al.

Patterns of salivary microbiota injury and oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation

.

Blood Adv

.

2020

;

4

(

13

):

2912

-

2917

.

118.

Rao

JN

,

Xiao

L

,

Wang

J-Y

.

Polyamines in gut epithelial renewal and barrier function

.

Physiology

.

2020

;

35

(

5

):

328

-

337

.

119.

Fahrmann

JF

,

Saini

NY

,

Chia-Chi

C

, et al.

A polyamine-centric, blood-based metabolite panel predictive of poor response to CAR-T cell therapy in large B cell lymphoma

.

Cell Rep Med

.

2022

;

3

(

11

):

100720

.

120.

Al-Habsi

M

,

Chamoto

K

,

Matsumoto

K

, et al.

Spermidine activates mitochondrial trifunctional protein and improves antitumor immunity in mice

.

Science

.

2022

;

378

(

6618

):

eabj3510

.

121.

Mager

LF

,

Burkhard

R

,

Pett

N

, et al.

Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy

.

Science

.

2020

;

369

(

6510

):

1481

-

1489

.

122.

DeFilipp

Z

,

Peled

JU

,

Li

S

, et al.

Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity

.

Blood Adv

.

2018

;

2

(

7

):

745

-

753

.

123.

Rashidi

A

,

Ebadi

M

,

Rehman

TU

, et al.

Randomized double-blind phase II trial of fecal microbiota transplantation versus placebo in allogeneic hematopoietic cell transplantation and AML

.

J Clin Orthod

.

2023

;

41

(

34

):

5306

-

5319

.

124.

Neemann

K

,

Eichele

DD

,

Smith

PW

,

Bociek

R

,

Akhtari

M

,

Freifeld

A

.

Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient

.

Transpl Infect Dis

.

2012

;

14

(

6

):

E161

-

E165

.

125.

de Castro

CG

,

Ganc

AJ

,

Ganc

RL

,

Petrolli

MS

,

Hamerschlack

N

.

Fecal microbiota transplant after hematopoietic SCT: report of a successful case

.

Bone Marrow Transplant

.

2015

;

50

(

1

):

145

.

126.

Battipaglia

G

,

Malard

F

,

Rubio

MT

, et al.

Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria

.

Haematologica

.

2019

;

104

(

8

):

1682

-

1688

.

127.

Kakihana

K

,

Fujioka

Y

,

Suda

W

, et al.

Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut

.

Blood

.

2016

;

128

(

16

):

2083

-

2088

.

128.

DeFilipp

Z

,

Damania

AV

,

Kim

HT

, et al.

Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract

.

Blood Advances

.

2024

;

8

(

9

):

2074

-

2084

.

129.

Rashidi

A

,

Ebadi

M

,

Rehman

TU

, et al.

Potential of fecal microbiota transplantation to prevent acute GVHD: analysis from a phase II trial

.

Clin Cancer Res

.

2023

;

29

(

23

):

4920

-

4929

.

130.

Rizvi

ZA

,

Dalal

R

,

Sadhu

S

, et al.

High-salt diet mediates interplay between NK cells and gut microbiota to induce potent tumor immunity

.

Sci Adv

.

2021

;

7

(

37

):

eabg5016

.

131.

Riwes

MM

,

Golob

JL

,

Magenau

J

, et al.

Feasibility of a dietary intervention to modify gut microbial metabolism in patients with hematopoietic stem cell transplantation

.

Nat Med

.

2023

;

29

(

11

):

2805

-

2813

.

132.

Nguyen

CL

,

Markey

KA

,

Miltiadous

O

, et al.

High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients

.

Cell

.

2023

;

186

(

12

):

2705

-

2718.e17

.

133.

Weber

D

,

Oefner

PJ

,

Dettmer

K

, et al.

Rifaximin preserves intestinal microbiota balance in patients undergoing allogeneic stem cell transplantation

.

Bone Marrow Transplant

.

2016

;

51

(

8

):

1087

-

1092

.

134.

Weber

D

,

Hiergeist

A

,

Weber

M

, et al.

Restrictive versus permissive use of broad-spectrum antibiotics in patients receiving allogeneic stem cell transplantation and with early fever due to cytokine release syndrome: evidence for beneficial microbiota protection without increase in infectious complications

.

Clin Infect Dis

.

2023

;

77

(

10

):

1432

-

1439

.

135.

Fernandez Sanchez

J

,

Maknojia

AA

,

King

KY

.

Blood and guts: how the intestinal microbiome shapes hematopoiesis and treatment of hematologic disease

.

Blood

.

2024

;

143

(

17

):

1689

-

1701

.

136.

Maghini

DG

,

Dvorak

M

,

Dahlen

A

, et al.

Quantifying bias introduced by sample collection in relative and absolute microbiome measurements

.

Nat Biotechnol

.

2024

;

42

(

2

):

328

-

338

.

137.

Duscha

A

,

Gisevius

B

,

Hirschberg

S

, et al.

Propionic acid shapes the multiple sclerosis disease course by an immunomodulatory mechanism

.

Cell

.

2020

;

180

(

6

):

1067

-

1080.e16

.

138.

Rangan

P

,

Mondino

A

.

Microbial short-chain fatty acids: a strategy to tune adoptive T cell therapy

.

J Immunother Cancer

.

2022

;

10

(

7

):

e004147

.

139.

Gabrielli

G

,

Shouval

R

,

Ghilardi

G

,

van den Brink

M

,

Ruella

M

.

Harnessing the gut microbiota to potentiate the efficacy of CAR T cell therapy

.

HemaSphere

.

2023

;

7

(

9

):

e950

.